Deals
Fresenius Bid for Pfizer’s Pumps Unit Said to Stall on Valuation
- Pfizer is resuming negotiations with buyout firms to sell unit
- Pfizer may still decide to keep the unit if no buyer is found
This article is for subscribers only.
Fresenius SE’s negotiations to acquire Pfizer Inc.’s pumps and devices business have stalled on valuation, according to people with knowledge of the matter.
Pfizer has decided to resume talks with private equity firms to try for a more attractive price for the business, which it acquired in last year’s purchase of Hospira Inc., two of the people said, asking not to be identified because the deliberations are private. Pfizer may return to negotiate with Fresenius or keep the assets if no agreement is reached with the buyout firms, they said.